FIELD: biopharmacology, medicine.
SUBSTANCE: claimed drug contains human granulocyte colony-stimulating factor (hG-CSF) as active ingredient. Disclosed are methods for treatment ob obstructive atheriosclerosis, ishemic diseases and other conditions by administering of abovementioned drug.
EFFECT: therapeutic agent of increased effectiveness.
16 cl, 5 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STEM CELL PROLIFERATION INHIBITOR AND STIMULANT AND USAGE THEREOF | 1997 |
|
RU2292352C9 |
| HEMOPOIETIC PROTEIN (VARIANTS), DNA SEQUENCE, METHOD FOR PREPARING HEMOPOIETIC PROTEIN, METHOD FOR SELECTIVE EXPANSION OF HEMOPOIETIC CELLS, METHOD FOR PRODUCING DENDRITIC CELLS, METHOD FOR STIMULATING FOR PRODUCING HEMOPOIETIC CELLS IN PATIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 1997 |
|
RU2245887C2 |
| GENE THERAPY IN PATIENTS WITH FANCONI ANEMIA | 2017 |
|
RU2801241C2 |
| PEPTIDE HAVING GROWTH-STIMULATING FACTOR OF HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR | 2008 |
|
RU2385875C2 |
| MESENCHYMAL STEM CELLS ORIGINATING FROM PERINATAL TISSUE: METHOD FOR THEIR PRODUCTION AND USE | 2017 |
|
RU2780179C2 |
| GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2799086C2 |
| INHIBITOR OF STEM CELL PROLIFERATION AND METHOD FOR ITS APPLICATION | 1995 |
|
RU2186579C2 |
| METHODS OF USING ZSCAN4 FOR HUMAN CELL REJUVENATION | 2014 |
|
RU2735141C2 |
| NK INVOLVING MOLECULES AND METHODS OF THEIR USE | 2019 |
|
RU2812481C2 |
| METHODS FOR GENE MODIFICATION OF HEMATOPOIETIC CELLS | 2019 |
|
RU2824194C2 |
